ALXO FY 2022 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$112M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$127M

Net Income

-$123M

EPS (Diluted)

$-3.03

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$91M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$306M

Total Liabilities

$43M

Stockholders' Equity

$263M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$127M	-$84M	-52.5%
Net Income	-$123M	-$83M	-47.9%